Cargando…

Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study

BACKGROUND: The incidence and prevalence of ulcerative colitis (UC) varies geographically. The risk of colorectal cancer (CRC) and possibly some other malignancies is increased among patients with UC. It is still debated if patients with UC are at a greater risk of dying compared with the general po...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunovszki, Péter, Milassin, Ágnes, Gimesi-Országh, Judit, Takács, Péter, Szántó, Kata, Bálint, Anita, Farkas, Klaudia, Borsi, András, Lakatos, Péter L., Szamosi, Tamás, Molnár, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224530/
https://www.ncbi.nlm.nih.gov/pubmed/32407408
http://dx.doi.org/10.1371/journal.pone.0233238
_version_ 1783533919729090560
author Kunovszki, Péter
Milassin, Ágnes
Gimesi-Országh, Judit
Takács, Péter
Szántó, Kata
Bálint, Anita
Farkas, Klaudia
Borsi, András
Lakatos, Péter L.
Szamosi, Tamás
Molnár, Tamás
author_facet Kunovszki, Péter
Milassin, Ágnes
Gimesi-Országh, Judit
Takács, Péter
Szántó, Kata
Bálint, Anita
Farkas, Klaudia
Borsi, András
Lakatos, Péter L.
Szamosi, Tamás
Molnár, Tamás
author_sort Kunovszki, Péter
collection PubMed
description BACKGROUND: The incidence and prevalence of ulcerative colitis (UC) varies geographically. The risk of colorectal cancer (CRC) and possibly some other malignancies is increased among patients with UC. It is still debated if patients with UC are at a greater risk of dying compared with the general population. Our aim was to describe the epidemiology and mortality of the Hungarian UC population from 2010 to 2016 and to analyze the associated malignancies with a special focus on CRC. METHODS: This is an observational, descriptive, epidemiological study based on the National Health Insurance Fund social security databases from 2010 to 2016. All adult patients who had at least two events in outpatient care or at least two medication prescriptions, or at least one inpatient event with UC diagnosis were analyzed. Malignancies and CRC were defined using ICD-10 codes. We also evaluated the survival of patients suffering from UC compared with the general population using a 3 to 1 matched random sample (age, gender, geography) from the full population of Hungary. RESULTS: We found the annual prevalence of UC 0.24–0.34%. The incidence in 2015 was 21.7/100 000 inhabitants. Annual mortality rate was 0.019–0.023%. In this subpopulation, CRC was the most common cancer, followed by non-melanotic skin and prostate cancer. 8.5% of the UC incident subpopulation was diagnosed with CRC. 470 (33%) of the CRC patients died during the course of the study (25% of all deaths were due to CRC), the median survival was 9.6 years. UC patients had significantly worse survival than their matched controls (HR = 1.65, 95% CI: 1.56–1.75). SUMMARY: This is the first population-based study from Eastern Europe to estimate the different malignancies and mortality data amongst Hungarian ulcerative colitis patients. Our results revealed a significantly worse survival of patients suffering from UC compared to the general population.
format Online
Article
Text
id pubmed-7224530
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72245302020-06-01 Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study Kunovszki, Péter Milassin, Ágnes Gimesi-Országh, Judit Takács, Péter Szántó, Kata Bálint, Anita Farkas, Klaudia Borsi, András Lakatos, Péter L. Szamosi, Tamás Molnár, Tamás PLoS One Research Article BACKGROUND: The incidence and prevalence of ulcerative colitis (UC) varies geographically. The risk of colorectal cancer (CRC) and possibly some other malignancies is increased among patients with UC. It is still debated if patients with UC are at a greater risk of dying compared with the general population. Our aim was to describe the epidemiology and mortality of the Hungarian UC population from 2010 to 2016 and to analyze the associated malignancies with a special focus on CRC. METHODS: This is an observational, descriptive, epidemiological study based on the National Health Insurance Fund social security databases from 2010 to 2016. All adult patients who had at least two events in outpatient care or at least two medication prescriptions, or at least one inpatient event with UC diagnosis were analyzed. Malignancies and CRC were defined using ICD-10 codes. We also evaluated the survival of patients suffering from UC compared with the general population using a 3 to 1 matched random sample (age, gender, geography) from the full population of Hungary. RESULTS: We found the annual prevalence of UC 0.24–0.34%. The incidence in 2015 was 21.7/100 000 inhabitants. Annual mortality rate was 0.019–0.023%. In this subpopulation, CRC was the most common cancer, followed by non-melanotic skin and prostate cancer. 8.5% of the UC incident subpopulation was diagnosed with CRC. 470 (33%) of the CRC patients died during the course of the study (25% of all deaths were due to CRC), the median survival was 9.6 years. UC patients had significantly worse survival than their matched controls (HR = 1.65, 95% CI: 1.56–1.75). SUMMARY: This is the first population-based study from Eastern Europe to estimate the different malignancies and mortality data amongst Hungarian ulcerative colitis patients. Our results revealed a significantly worse survival of patients suffering from UC compared to the general population. Public Library of Science 2020-05-14 /pmc/articles/PMC7224530/ /pubmed/32407408 http://dx.doi.org/10.1371/journal.pone.0233238 Text en © 2020 Kunovszki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kunovszki, Péter
Milassin, Ágnes
Gimesi-Országh, Judit
Takács, Péter
Szántó, Kata
Bálint, Anita
Farkas, Klaudia
Borsi, András
Lakatos, Péter L.
Szamosi, Tamás
Molnár, Tamás
Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title_full Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title_fullStr Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title_full_unstemmed Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title_short Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study
title_sort epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in hungary – a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224530/
https://www.ncbi.nlm.nih.gov/pubmed/32407408
http://dx.doi.org/10.1371/journal.pone.0233238
work_keys_str_mv AT kunovszkipeter epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT milassinagnes epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT gimesiorszaghjudit epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT takacspeter epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT szantokata epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT balintanita epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT farkasklaudia epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT borsiandras epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT lakatospeterl epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT szamositamas epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy
AT molnartamas epidemiologymortalityandprevalenceofcolorectalcancerinulcerativecolitispatientsbetween20102016inhungaryapopulationbasedstudy